1.46
+0.075(+5.43%)
Currency In USD
| Previous Close | 1.38 |
| Open | 1.4 |
| Day High | 1.46 |
| Day Low | 1.38 |
| 52-Week High | 10.77 |
| 52-Week Low | 1.38 |
| Volume | 170,265 |
| Average Volume | 406,313 |
| Market Cap | 70.4M |
| PE | -0.13 |
| EPS | -11.05 |
| Moving Average 50 Days | 2.12 |
| Moving Average 200 Days | 2.86 |
| Change | 0.08 |
If you invested $1000 in Cibus, Inc. (CBUS) since IPO date, it would be worth $2.59 as of July 01, 2025 at a share price of $1.455. Whereas If you bought $1000 worth of Cibus, Inc. (CBUS) shares 5 years ago, it would be worth $6.19 as of July 01, 2025 at a share price of $1.455.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
GlobeNewswire Inc.
Jun 24, 2025 11:00 AM GMT
Completion of the U.S. Food and Drug Administration’s Plant Biotechnology Consultation Program enables U.S. commercialization of alfalfa with an altered lignin profile offering potential improved digestibility for livestock and greater harvest flexib
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
GlobeNewswire Inc.
Jun 12, 2025 12:00 PM GMT
Researchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration with the potential to introduce th
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
GlobeNewswire Inc.
Jun 10, 2025 12:22 AM GMT
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteri